Statement Of Changes In Equity [Abstract]

Xspray Pharma - Filing #690674

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Increase (decrease) through exercise of warrants, equity
SEK
175,000 SEK
4 200 SEK
4 375 SEK
SEK
Increase (decrease) through transactions with owners, equity
2 000 SEK
SEK
95 937 SEK
SEK
93 937 SEK
SEK
1 787 SEK
104 075 SEK
105 862 SEK
SEK
Share issue related cost
SEK
- SEK
4 876 SEK
SEK
4 876 SEK
SEK
SEK
134,000 SEK
134,000 SEK
SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.